Announcement
14 Dec 2021
In December 2021, Malaysia provided a clinical trial import license to import Molnupiravir for Merck Sharpe & Dohme (Malaysia) Sdn and Patheon Pharmaceuticals Inc.
Source
Sign in to access
Number of interventions
1
0 certainly harmful
0 likely harmful
1 liberalising
List of interventions
Implementation date
14 Dec 2021
Revocation date:
14 Sep 2022
Announced: 14 Dec 2021
Import licensing requirement
On 14 December 2021, Malaysia’s National Pharmaceutical Regulatory Agency approved a clinical trial import license to import Molnupiravir for Merck Sharpe & Dohme (Malaysia) Sdn and Patheon Pharma...
Sign in to see more
Threads
See all
Liberalising Trade Policy Measures
This Thread tracks liberalising trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
14590
interventions
186
jurisdictions